People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Biotech / Pharma, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vedanta Biosciences, Inc. | — | Biotech / Pharma | Series D+ | $240.3M | $2.0B | 2021 |
| scPharmaceuticals Inc. | — | Pharmaceuticals | Series C | $71.8M | $1.6B | 2016 |
| Juventas Therapeutics Inc | — | Biotechnology | Series B | $35.8M | $52.0M | 2015 |
Troy Ignelzi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Troy Ignelzi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somu Subramaniam | 1 | 17 |
| Jonathan Silverstein | 1 | 10 |
| Kush Parmar | 1 | 10 |
| Curt LaBelle | 1 | 7 |
| George Arida | 1 | 6 |
| Mette Kirstine Agger | 1 | 6 |
| Martin Heidecker | 1 | 6 |
| Linda Tufts | 1 | 5 |
| Roger Newton | 1 | 4 |
| Marc Penn | 1 | 4 |
| NEIL TIWARI | 1 | 4 |
| George Emont | 1 | 4 |
| Rahul Aras | 1 | 3 |
| Suzette Dutch | 1 | 3 |
| Bharatt Chowrira | 1 | 3 |
| Pieter Muntendam | 1 | 2 |
| Christopher Viehbacher | 1 | 2 |
| Bennett Shapiro | 1 | 2 |
| John LaMattina | 1 | 2 |
| Matt Pollman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.